Issac R. Schwantes

Oregon Health & Science University — United States

Medicine · Health Sciences

5h-index143citations19works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(6), Pancreatic and Hepatic Oncology Research(6), Cancer Genomics and Diagnostics(4), Liver Disease and Transplantation(2), Renal Transplantation Outcomes and Treatments(2)

Publications19 total

Novel Agents and Drug Development
2025
ASO Author Reflections: Is It Time to Re-evaluate Floxuridine Dosing for Hepatic Arterial Infusion?
Annals of Surgical Oncology·2024· 1 cited
ASO Visual Abstract: A Modified Floxuridine Reduced-Dose Protocol for Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion
Annals of Surgical Oncology·2024
A Modified Floxuridine Reduced-Dose Protocol for Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion
Annals of Surgical Oncology·2024· 5 cited
Safety and Effectiveness of Portal Vein Embolization after Hepatic Arterial Infusion Therapy
Journal of Vascular and Interventional Radiology·2024
Clinician overconfidence in visual estimation of the posthepatectomy liver remnant volume: A proximal source of liver failure after major hepatic resection?
Surgery·2024· 2 cited
The Hallmarks of Circulating Hybrid Cells
Results and problems in cell differentiation·2023· 1 cited
Metastasectomy for metastatic melanoma in the era of effective systemic therapy
The American Journal of Surgery·2023· 6 cited
The genomics of liver metastases from colon and rectal cancer: An Invited Commentary (invitation from Lee Ocuin, MD and Kevin Behrns, MD) for the special issue of “Management of Advanced Primary and Secondary Liver Malignancies”
Surgery·2023
Neoadjuvant therapy does not impact the biliary microbiome in patients with pancreatic cancer
Journal of Surgical Oncology·2023· 3 cited
Referral and treatment patterns in pancreatic acinar cell carcinoma: A regional population-level analysis
The American Journal of Surgery·2023· 4 cited
Care at high‐volume centers is associated with improved outcomes for patients with pancreatic neuroendocrine tumors: A population‐level analysis
Journal of Surgical Oncology·2023· 2 citedOpen Access
Delayed adjuvant endocrine therapy is associated with decreased recurrence-free survival following neoadjuvant chemotherapy for breast cancer
The American Journal of Surgery·2023· 1 cited
High-volume centers are associated with higher receipt of combined therapy in stage III pancreatic cancer
The American Journal of Surgery·2023· 1 cited
Updated Management of Colorectal Cancer Liver Metastases: Scientific Advances Driving Modern Therapeutic Innovations
Cellular and Molecular Gastroenterology and Hepatology·2023· 36 citedOpen Access
The need for integrated clinical and administrative data models for risk adjustment in assessment of the cost transplant care
Clinical Transplantation·2022· 4 cited
Technology-Enabled Care and Artificial Intelligence in Kidney Transplantation
Current Transplantation Reports·2021· 42 citedOpen Access
Using the Flipped Classroom Model in Surgical Education: Efficacy and Trainee Perception
Journal of surgical education·2021· 29 cited
A simple risk‐based reimbursement system for kidney transplant
Clinical Transplantation·2020· 6 cited

Frequent Co-authors

Ranish K. Patel(11), Skye C. Mayo(9), Thomas L. Sutton(6), Shay Behrens(6), Adel Kardosh(4), Charles D. Lopez(4), Brett C. Sheppard(4), David A. Axelrod(3), Robert Eil(3), Alicia J. Johnson(3), Rodney F. Pommier(3), Shahrose Rahman(2), Flavio G. Rocha(2), Melissa H. Wong(2), Mark A. Schnitzler(2), Krista L. Lentine(2), Ramji Balakrishnan(2), Jillian Paxton(2), Emerson Y. Chen(2), Flavio G. Rocha(2)